The increasing need to consider rationing strategies within the health
care environment is being driven by pressures such as the development
of new medical technologies, the aging population, patient awareness a
nd expectations, healthcare professionals' appetite for new treatments
, and government restrictions on healthcare costs. Solutions to these
pressures will need to be sought urgently to avoid a situation in whic
h quality of healthcare is affordable only for the wealthy. The fundam
ental principles of equity and fairness will need to be applied univer
sally if the solutions are to be accepted by the community, patients a
nd practitioners. There are several measures that a hospital must have
in place before the concept of drug rationing can be contemplated. Th
e approach essentially involves ensuring rational drug approval proces
ses based on critical review of the available data, coupled with ongoi
ng education and audit. Thus, accurate information and clinical budget
ing systems, processes which encourage and ensure structural and techn
ical efficiencies within the drug use sequence and an effective Drug a
nd Therapeutics committee are required to facilitate this approach. To
assist with its overriding goals of the quality use of medicines and
optimal patient care, the Drug and Therapeutics committee needs to imp
lement an effective formulary system, obtain detailed guidelines gover
ning drug use within the institution, conduct an ongoing drug utilisat
ion review programme, and provide education and training. The move to
consider allocative decision making (rationing) will become increasing
ly necessary as limits on structural and technical efficiency measures
are reached. An institution will then need to decide whether to treat
a particular group of patients, or provide a certain form of treatmen
t. improved methods for community consultation need to be explored and
there must be a partnership between the health provider and the consu
mer in enunciating the existence of scarcity, determining priorities a
nd ensuring that ethics and equity are not abandoned through this proc
ess.